132 related articles for article (PubMed ID: 36375658)
21. Hsp90ab1 stabilizes LRP5 to promote epithelial-mesenchymal transition via activating of AKT and Wnt/β-catenin signaling pathways in gastric cancer progression.
Wang H; Deng G; Ai M; Xu Z; Mou T; Yu J; Liu H; Wang S; Li G
Oncogene; 2019 Feb; 38(9):1489-1507. PubMed ID: 30305727
[TBL] [Abstract][Full Text] [Related]
22. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
23. Molecular classification of basal cell carcinoma of skin by gene expression profiling.
Jee BA; Lim H; Kwon SM; Jo Y; Park MC; Lee IJ; Woo HG
Mol Carcinog; 2015 Dec; 54(12):1605-12. PubMed ID: 25328065
[TBL] [Abstract][Full Text] [Related]
24. Expression of RUNX3 in skin cancers.
Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of heat shock protein HSP90ab1 in radiation-damaged lung cells other than mast cells.
Haase MG; Geyer P; Fitze G; Baretton GB
J Histochem Cytochem; 2014 May; 62(5):355-68. PubMed ID: 24670792
[TBL] [Abstract][Full Text] [Related]
26. Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A), and stimulates Il1a transcription in rat Sertoli cells.
Tash JS; Chakrasali R; Jakkaraj SR; Hughes J; Smith SK; Hornbaker K; Heckert LL; Ozturk SB; Hadden MK; Kinzy TG; Blagg BS; Georg GI
Biol Reprod; 2008 Jun; 78(6):1139-52. PubMed ID: 18218611
[TBL] [Abstract][Full Text] [Related]
27. Evidence that dysregulated DNA mismatch repair characterizes human nonmelanoma skin cancer.
Young LC; Listgarten J; Trotter MJ; Andrew SE; Tron VA
Br J Dermatol; 2008 Jan; 158(1):59-69. PubMed ID: 17970804
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
29. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
30. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
31. Expression of Transient Receptor Potential Channel of Melastatin number 8 (TRPM8) in Non- Melanoma Skin Cancer: A Clinical and Immunohistochemical study.
Hemida AS; Hammam MA; Heriz NAEM; Shehata WA
J Immunoassay Immunochem; 2021 Nov; 42(6):620-632. PubMed ID: 33896372
[TBL] [Abstract][Full Text] [Related]
32. High numbers of human skin cancers express MMP2 and several integrin genes.
Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
34. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
35. P16INK4a Immunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran.
Ramezani M; Abdali E; Khazaei S; Vaisi-Raygani A; Sadeghi M
Asian Pac J Cancer Prev; 2016; 17(3):1093-6. PubMed ID: 27039730
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A; Dunne C; O'Kelly P; Murphy GM; Leader M; Kay E
Histopathology; 2007 Dec; 51(6):793-804. PubMed ID: 18042068
[TBL] [Abstract][Full Text] [Related]
37. Sialic acid differential expression in non-melanoma skin cancer biopsies.
Ferreira SA; Vasconcelos JL; Cavalcanti CL; Rêgo MJ; Beltrão EI
Med Mol Morphol; 2013 Dec; 46(4):198-202. PubMed ID: 23508708
[TBL] [Abstract][Full Text] [Related]
38. Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders.
Voss KE; Bollag RJ; Fussell N; By C; Sheehan DJ; Bollag WB
Arch Dermatol Res; 2011 Oct; 303(8):591-600. PubMed ID: 21400035
[TBL] [Abstract][Full Text] [Related]
39. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.
Marcil I; Stern RS
Arch Dermatol; 2000 Dec; 136(12):1524-30. PubMed ID: 11115165
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
